NOV 17, 2020 6:45 AM PST

6 Injections a Year Prevent HIV Infections

WRITTEN BY: Tara Fernandez

Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging results emerging from a clinical trial of an investigational drug is providing hope to these women in the form of a reliable prophylactic therapy. The injectable drug, cabotegravir, was found to be more effective than the once-a-day preventative pill Truvada (Gilead), the current gold standard for pre-exposure prophylaxis.

A group of international collaborators came together as part of the H.I.V. Prevention Trials Network to conduct the randomized, double-blind clinical trial in a cohort of over 3,000 participants across seven African countries. Their goal was to compare the efficacy of Truvada with the new drug. 

HIV affects the immune system by infecting white blood cells called CD4-positive T cells. The virus is incapable of reproducing on its own. Therefore, it relies entirely on the infected T cell to do the heavy lifting. The virus attaches to the immune cell, fusing its envelope with the cell membrane before hijacking the nucleus of the cell, forcing it to make copies of itself using the cellular machinery. More viruses are subsequently released into the blood, multiplying and weakening the body’s natural defenses over time.

The results of the trial were groundbreaking: the injection was 89 percent more effective than Truvada, compelling researchers to end the trial early. Cabotegravir is an integrase inhibitor, a type of antiretroviral that blocks the viral enzyme integrase from inserting the HIV genome into the host cell’s DNA. Besides its improved efficacy, the treatment has clear advantages over existing HIV prophylactics: individuals only need to get a shot once every couple of months and the drug does not require refrigeration, allowing mobile clinics to administer it to women together with injectable birth controls.

One drawback is that there is a higher risk of viral resistance in the event that the injection schedule is disrupted. “If you go too long, and you get exposed to H.I.V., you could get a drug-resistant virus, so every eight weeks is going to be mandatory,” said Dr. Monica Gandhi, an H.I.V. expert at the University of California, San Francisco. “And because of that, to keep adherence to that type of schedule, we have to be creative.”

 

 

Sources: New York Times, World Health Organization.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 28, 2021
Cell & Molecular Biology
Bringing Light to Extracellular Vesicles
JUN 28, 2021
Bringing Light to Extracellular Vesicles
Though originally thought of as strictly a waste disposal system, extracellular vesicles (EVs) have been shown to have m ...
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
JUL 27, 2021
Cell & Molecular Biology
Nanobodies May Prevent Complications From Infection in Transplant Recipents
JUL 27, 2021
Nanobodies May Prevent Complications From Infection in Transplant Recipents
In recent years, scientists java turned their attention to small antibodies that are produced by animals like sharks, ca ...
AUG 05, 2021
Technology
Top Ways to Make the Most out of Your Ethernet
AUG 05, 2021
Top Ways to Make the Most out of Your Ethernet
Today, the Ethernet connection has emerged as one of the most popular ways to make the most out of an internet connectio ...
AUG 12, 2021
Health & Medicine
Why Autoimmune Diseases Strike Women More Often Than Men
AUG 12, 2021
Why Autoimmune Diseases Strike Women More Often Than Men
According to a 2020 study published in Cureus, autoimmune diseases are two times more prevalent in women than men, with ...
Loading Comments...